PMC9831652_01
Pancreatic tail/body cancer (red arrow) with multiple liver lesions.
rjac638f1.jpg
PMC9831652_01_rjac638f1.jpg
f1
Small peripancreatic lymph nodes were also noted (Fig. 1).
Status post-multimodal therapy with significant lesional downsizing or complete vanishing of cancerous lesions.
rjac638f2.jpg
PMC9831652_01_rjac638f2.jpg
f2
A follow-up CT scan confirmed that all remaining LMs in the right lobe had significantly decreased in size or vanished (Fig. 2).
Substantial CEA response after multimodal therapy.
rjac638f3.jpg
PMC9831652_01_rjac638f3.jpg
f3
Tumor markers (CA19-9 and CEA) decreased continuously to normal levels (Figs. 3 and 4).
Considerable CA19-9 response after multimodal therapy.
rjac638f4.jpg
PMC9831652_01_rjac638f4.jpg
f4
Tumor markers (CA19-9 and CEA) decreased continuously to normal levels (Figs. 3 and 4).
(A) Two brain metastases. (B) Status after surgical intervention on the bigger lesion.
rjac638f5.jpg
PMC9831652_01_rjac638f5.jpg
f5
Histology was consistent with metastatic PDAC (Fig. 5).